Hawkhill Therapeutics Ltd is a biotech spin-out company from Tay Therapeutics based in Dundee, UK, focusing on scientific research and the delivery of new therapies.
Subscribe to see Hawkhill Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Hawkhill Therapeutics is a life sciences company headquartered in United Kingdom. Its most recent funding round raised $290,530 in April 2026. Xcout tracks 10 named people at Hawkhill Therapeutics, including Conor Woolfson (CFO/COO).
4 more named people on record for Hawkhill Therapeutics, with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $290,530 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Hawkhill Therapeutics's closest competitors — see the full list of competitors and alternatives →
Mironid Limited is a privately held drug discovery company founded in 2015 and headquartered in Glasgow, Scotland. The patient-focused company develops innovative therapeutics to improve the treatment of various medical conditions.
Pathios Therapeutics Limited is a biotech company established in 2017 and registered in England and Wales, focusing on the discovery and development of first-in-class therapies.
Apollo Therapeutics is a biopharmaceutical company with headquarters located in Cambridge, United Kingdom, alongside offices in Boston, Massachusetts. The company advances breakthrough science to build a portfolio of innovative therapeutics.
NanoSyrinx Ltd. is a biotechnology company incorporated in England and Wales with headquarters in Warwick, focused on advancing targeted drug delivery platforms.
Dunad Therapeutics is a transatlantic biotech company with operations in Cambridge, United Kingdom, and Boston in the United States. The company focuses on innovative therapeutics research and development with a small team of specialized scientists.
Oak Hill Bio is a clinical-stage biotechnology company focused on acquiring and developing rare disease drugs that have been deprioritized by other organizations. Formed in 2024 as a subsidiary of Oak Hill Bio Holdings, the company operates under the trading name OHB Pediatrics Ltd and is headquartered in Altrincham, United Kingdom.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.